Cita APA (7a ed.)
Ali, A., Bayan, A., Barakat, D., Abu-Gheyab, R., Ismail-Agha, D., Awatef, A., & Nawfal, N. (2025). In Vitro Activity of Cefaclor/Beta-Lactamases Inhibitors (Clavulanic Acid and Sulbactam) Combination Against Extended-Spectrum Beta-Lactamase Producing Uropathogenic E. coli. Antibiotics. https://doi.org/10.3390/antibiotics14060603
Cita Chicago Style (17a ed.)
Ali, Atoom, Alzubi Bayan, Dana Barakat, Rana Abu-Gheyab, Dalia Ismail-Agha, Al-Kaabneh Awatef, y Numan Nawfal. "In Vitro Activity of Cefaclor/Beta-Lactamases Inhibitors (Clavulanic Acid and Sulbactam) Combination Against Extended-Spectrum Beta-Lactamase Producing Uropathogenic E. Coli." Antibiotics 2025. https://doi.org/10.3390/antibiotics14060603.
Cita MLA (9a ed.)
Ali, Atoom, et al. "In Vitro Activity of Cefaclor/Beta-Lactamases Inhibitors (Clavulanic Acid and Sulbactam) Combination Against Extended-Spectrum Beta-Lactamase Producing Uropathogenic E. Coli." Antibiotics, 2025, https://doi.org/10.3390/antibiotics14060603.
Precaución: Estas citas no son 100% exactas.